Malignant hyperthermia syndrome : case report
Malignant hyperthermia syndrome is a family myopathy of pharmacogenetic nature, which appears as a skeletal muscle hypercatabolic syndrome linked to anesthesia. The incidence in pediatrics is 1 event per 10 000 surgeries. The clinical picture may have a rapid onset associated with succinylcholine, or a late onset related to inhalation agents. The clinical picture includes tachycardia, hyperthermia, hypercapnia, acidosis, muscle rigidity, hyperkalemia, renal failure and arrhythmia. Mortality without specific treatment is of 80% and drops to 7% with the use of dantrolene sodium. We report an 8-year-old patient admitted for phimosis surgery; having tachycardia, hypercapnia and muscle rigidity, he started treatment with dantrolene sodium in the operating room, which was maintained for 72 hours. He evolved the first 12 hours with low cardiac output and creatine phosphokinase maximum of 155,147 U/L. He remained with mechanical ventilation for 48 hours. Discharge was given on the sixth day without sequelae.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:113 |
---|---|
Enthalten in: |
Archivos argentinos de pediatria - 113(2015), 2 vom: 07. Apr., Seite e113-6 |
Sprache: |
Spanisch |
---|
Weiterer Titel: |
Sindrome de hipertermia maligna: a propositio de un caso clinico |
---|
Beteiligte Personen: |
Taffarel, Pedro [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 19.01.2017 Date Revised 23.01.2017 published: Print Citation Status MEDLINE |
---|
doi: |
10.5546/aap.2015.e113 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM246664746 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM246664746 | ||
003 | DE-627 | ||
005 | 20231224143546.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2015 xx |||||o 00| ||spa c | ||
024 | 7 | |a 10.5546/aap.2015.e113 |2 doi | |
028 | 5 | 2 | |a pubmed24n0822.xml |
035 | |a (DE-627)NLM246664746 | ||
035 | |a (NLM)25727836 | ||
035 | |a (PII)S0325-00752015000200022 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a spa | ||
100 | 1 | |a Taffarel, Pedro |e verfasserin |4 aut | |
245 | 1 | 0 | |a Malignant hyperthermia syndrome |b case report |
246 | 3 | 3 | |a Sindrome de hipertermia maligna: a propositio de un caso clinico |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.01.2017 | ||
500 | |a Date Revised 23.01.2017 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Malignant hyperthermia syndrome is a family myopathy of pharmacogenetic nature, which appears as a skeletal muscle hypercatabolic syndrome linked to anesthesia. The incidence in pediatrics is 1 event per 10 000 surgeries. The clinical picture may have a rapid onset associated with succinylcholine, or a late onset related to inhalation agents. The clinical picture includes tachycardia, hyperthermia, hypercapnia, acidosis, muscle rigidity, hyperkalemia, renal failure and arrhythmia. Mortality without specific treatment is of 80% and drops to 7% with the use of dantrolene sodium. We report an 8-year-old patient admitted for phimosis surgery; having tachycardia, hypercapnia and muscle rigidity, he started treatment with dantrolene sodium in the operating room, which was maintained for 72 hours. He evolved the first 12 hours with low cardiac output and creatine phosphokinase maximum of 155,147 U/L. He remained with mechanical ventilation for 48 hours. Discharge was given on the sixth day without sequelae | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Dantrolene |2 NLM | |
650 | 7 | |a F64QU97QCR |2 NLM | |
700 | 1 | |a Koffman, Fernando |e verfasserin |4 aut | |
700 | 1 | |a Zifferman, Andrea |e verfasserin |4 aut | |
700 | 1 | |a Degiuseppe, Sebastián |e verfasserin |4 aut | |
700 | 1 | |a Mansilla, Alejandro |e verfasserin |4 aut | |
700 | 1 | |a Darduin, Marcelo |e verfasserin |4 aut | |
700 | 1 | |a Acerenza, Marcelo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Archivos argentinos de pediatria |d 1945 |g 113(2015), 2 vom: 07. Apr., Seite e113-6 |w (DE-627)NLM040810917 |x 1668-3501 |7 nnns |
773 | 1 | 8 | |g volume:113 |g year:2015 |g number:2 |g day:07 |g month:04 |g pages:e113-6 |
856 | 4 | 0 | |u http://dx.doi.org/10.5546/aap.2015.e113 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 113 |j 2015 |e 2 |b 07 |c 04 |h e113-6 |